40° Partly Cloudy

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition
STOCKING STUFFER CONTEST

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

12.81 +0.05 (+0.39%)

Streaming Delayed Price Updated: 12:41 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

NOVOCURE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against NovoCure Limited and Encourages Investors to Contact the Firm

June 19, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors

June 16, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into NovoCure Limited (NVCR)

June 16, 2023

From Scott+Scott Attorneys at Law LLP

Via Business Wire

The Latest Analyst Ratings for NovoCure ↗

June 06, 2023

Via Benzinga

Why NovoCure Stock Is Crashing Today ↗

June 06, 2023

Analysts weren't wowed by the company's late-stage data.

Via The Motley Fool

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors

June 15, 2023

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors

June 15, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon ↗

June 12, 2023

These three small cap drug companies could become gold or lead depending on the outcomes of their clinical trials.

Via InvestorPlace

This Beaten-Down Growth Stock Has 99% Upside, According to Wall Street ↗

June 12, 2023

A big turnaround could be in the cards for this medical device maker.

Via The Motley Fool

NovoCure's Return On Capital Employed Overview ↗

May 18, 2023

Via Benzinga

Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review ↗

June 09, 2023

The Nasdaq held near 52-week highs while small caps ramped up.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Wednesday ↗

June 07, 2023

On Wednesday, 29 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023 ↗

June 07, 2023

Via Benzinga

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the Firm

June 07, 2023

From The Schall Law Firm

Via Business Wire

These 2 Nasdaq Stocks Are Plunging. Here's Why ↗

June 06, 2023

Tuesday brought optimism to the stock market overall, but not for these companies.

Via The Motley Fool

Dow Falls Over 100 Points; Hoth Therapeutics Shares Spike Higher ↗

June 06, 2023

U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Tuesday. The Dow traded down 0.36% to 33,440.78 while the NASDAQ rose 0.09% to 13,241.04. The S&P 500,...

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the Firm

June 06, 2023

From The Schall Law Firm

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

June 06, 2023

On Tuesday, 69 stocks hit new 52-week lows.

Via Benzinga

Stocks Mixed As VIX Extends Lows ↗

June 06, 2023

Stocks are struggling for direction midday.

Via Talk Markets

Novocure's Cancer Treating Electric Fields Improves Survival In Lung Cancer Patients, But Stock Tumbles On Remaining Doubts ↗

June 06, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 06, 2023

Via Benzinga

Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 06, 2023

Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.

Via Benzinga

Nasdaq Edges Higher; Joann Shares Plummet ↗

June 06, 2023

U.S. stocks traded mixed midway through trading, with Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.08% to 33,534.50 while the NASDAQ rose 0.27% to 13,265.27. The S&P 500, also...

Via Benzinga

Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday ↗

June 06, 2023

U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Novocure Crashes Almost 30% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment ↗

June 06, 2023

Novocure said its device, Optune, extended overall survival by more than three months for some lung cancer patients.

Via Investor's Business Daily

Dow Drops 50 Points; J.M. Smucker Earnings Top Views ↗

June 06, 2023

U.S. stocks traded lower this morning, with Dow Jones dropping around 50 points on Monday. The Dow traded down 0.16% to 33,509.87 while the NASDAQ fell 0.19% to 13,203.91. The S&P 500, also fell,...

Via Benzinga

Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies

June 06, 2023

From Zai Lab Limited

Via GlobeNewswire

LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies

June 06, 2023

From Novocure

Via Business Wire

Novocure Pledges $3 Million to Conquer Cancer®, the ASCO Foundation, to Support Cancer Research and Education

June 01, 2023

From Novocure

Via Business Wire

3 No-Brainer Stocks to Buy for Under $100 Right Now ↗

May 27, 2023

These stocks might not remain under $100 for too much longer.

Via The Motley Fool

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

NovoCure Limited - Ordinary Shares (NQ:NVCR)

All News about NovoCure Limited - Ordinary Shares

Sections

Services